Publication | Closed Access

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

UrologyDisease ProgressionGenitourinary CancerMedicineAdvanced Prostate CancerPharmacotherapyCancer TreatmentProstatic DiseaseOncologyImmediate Therapy